Clinical Trial Update: Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating atorvastatin use in patients with hepatitis B virus-related liver cirrhosis and portal hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Portal Hypertension

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Hepatitis B, Portal Hypertension | Phase 2 | Status: UNKNOWN